Search All News
Dr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
Columbia researchers have published their first report on mass shootings from the Columbia Mass Murder Database (CMMD).
Source:New York TimesJanuary 14, 2020
Dr. Mark Olfson said looking at large groups, instead of homing in on specific individuals, allows for other factors to affect the suicide rates — even if the study tried to control for some of them.
- January 13, 2020
Researchers at Columbia University used magnetic resonance imaging (MRI) to understand brain structural alterations in children and adolescents with OCD that predict psychotherapy treatment response.
- January 10, 2020
A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that prenatal exposure to flame retardants may increase the risk of reading problems.
Source:MedscapeJanuary 9, 2020
"We were surprised to learn that there has been a larger decrease in opioid prescribing to adults with more rather than less severe pain," Dr. Mark Olfson said.
Source:MD MagazineDecember 23, 2019
“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.
Source:U.S. NewsDecember 17, 2019
"Considering the high risk of suicide after nonfatal opioid overdose, this information could be especially valuable in suicide prevention efforts," Dr. Mark Olfson said.
Source:Daily MailDecember 17, 2019
'It's likely that the increasing use of illicit fentanyl has contributed to the rapid increase in unintentional opioid overdose deaths,' explained Dr Mark Olfson.
- December 17, 2019
Opioid-related suicides account for only 4% of opioid-related deaths, far below previous estimates of 20% to 30%, a new study from Columbia University has found.